5-(123)I-A-85380 binding to the α4β2-nicotinic receptor in mild cognitive impairment.
Treatments currently licensed for Alzheimer's dementia target cholinergic brain systems. In vivo nicotinic receptor binding may provide an early marker of illness and treatment suitability. In this pilot, we examined nine patients with amnestic mild cognitive impairment (MCI) and 10 age and edu...
Main Authors: | Terrière, E, Dempsey, M, Herrmann, L, Tierney, K, Lonie, J, O'Carroll, R, Pimlott, S, Wyper, D, Herholz, K, Ebmeier, K |
---|---|
格式: | Journal article |
語言: | English |
出版: |
2010
|
相似書籍
-
Dual task performance in early Alzheimer's disease, amnestic mild cognitive impairment and depression.
由: Lonie, J, et al.
出版: (2009) -
alpha4beta2-nicotinic receptor binding with 5-IA in Alzheimer's disease: methods of scan analysis.
由: Terrière, E, et al.
出版: (2008) -
Predicting outcome in mild cognitive impairment: 4-year follow-up study.
由: Lonie, J, et al.
出版: (2010) -
MRI correlates of episodic memory in Alzheimer's disease, mild cognitive impairment, and healthy aging.
由: Sexton, C, et al.
出版: (2010) -
Screening for mild cognitive impairment: a systematic review.
由: Lonie, J, et al.
出版: (2009)